Treace Medical Concepts, Inc. Investment Income, Net
Treace Medical Concepts, Inc. (TMCI) reported Investment Income, Net of $445.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeNet · last filed 2026-08-07
- Treace Medical Concepts, Inc. investment income, net for the quarter ending 2026-06-30 was $445.00K, a 42.58% decline year-over-year.
- Treace Medical Concepts, Inc. investment income, net for the quarter ending 2026-03-31 was $501.00K, a 40.43% decline year-over-year.
- Treace Medical Concepts, Inc. investment income, net for the quarter ending 2025-12-31 was $527.00K, a 41.38% decline year-over-year.
- Treace Medical Concepts, Inc. investment income, net for the quarter ending 2025-09-30 was $634.00K, a 40.58% decline year-over-year.
- Treace Medical Concepts, Inc. investment income, net for fiscal 2023 was $6.73M, a 412.26% increase from fiscal 2022.
- Treace Medical Concepts, Inc. investment income, net for fiscal 2022 was $1.31M, a 7623.53% increase from fiscal 2021.
- Treace Medical Concepts, Inc. investment income, net for fiscal 2021 was $17.00K.
- Treace Medical Concepts, Inc. investment income, net for fiscal 2020 was -$1.75M, a 1672.97% decline from fiscal 2019.
| Period end | Investment Income, Net 3 month | Investment Income, Net 3 month as first filed | Investment Income, Net 6 month | Investment Income, Net 6 month as first filed | Investment Income, Net 9 month | Investment Income, Net 9 month as first filed | Investment Income, Net 12 month | Investment Income, Net 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $445.00K 10-Q · filed 2026-08-07 | $946.00K 10-Q · filed 2026-08-07 | $1.47M derived: sum of 3 quarters · filed 2026-08-07 | $2.11M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | $501.00K 10-Q · filed 2026-05-08 | $1.03M derived: sum of 2 quarters · filed 2026-05-08 | $1.66M derived: sum of 3 quarters · filed 2026-05-08 | $2.44M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-12-31 | $527.00K DEF 14A · filed 2026-04-06 | $1.16M derived: sum of 2 quarters · filed 2026-04-06 | $1.94M derived: sum of 3 quarters · filed 2026-08-07 | $2.78M DEF 14A · filed 2026-04-06 | ||||
| 2025-09-30 | $634.00K 10-Q · filed 2025-11-06 | $1.41M derived: sum of 2 quarters · filed 2026-08-07 | $2.25M 10-Q · filed 2025-11-06 | $3.15M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | $775.00K 10-Q · filed 2026-08-07 | $1.62M 10-Q · filed 2026-08-07 | $2.52M derived: sum of 3 quarters · filed 2026-08-07 | $3.58M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-03-31 | $841.00K 10-Q · filed 2026-05-08 | $1.74M derived: sum of 2 quarters · filed 2026-05-08 | $2.81M derived: sum of 3 quarters · filed 2026-05-08 | $4.18M derived: sum of 4 quarters · filed 2026-05-08 | ||||
| 2024-12-31 | $899.00K DEF 14A · filed 2026-04-06 | $1.97M derived: sum of 2 quarters · filed 2026-04-06 | $3.34M derived: sum of 3 quarters · filed 2026-04-06 | $4.88M DEF 14A · filed 2026-04-06 | ||||
| 2024-09-30 | $1.07M 10-Q · filed 2025-11-06 | $2.44M derived: sum of 2 quarters · filed 2025-11-06 | $3.98M 10-Q · filed 2025-11-06 | $5.69M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2024-06-30 | $1.38M 10-Q · filed 2025-08-07 | $2.91M 10-Q · filed 2025-08-07 | $4.62M derived: sum of 3 quarters · filed 2026-02-27 | $6.19M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2024-03-31 | $1.53M 10-Q · filed 2025-05-08 | $3.24M derived: sum of 2 quarters · filed 2026-02-27 | $4.81M derived: sum of 3 quarters · filed 2026-02-27 | $6.78M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2023-12-31 | $1.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $3.28M derived: sum of 2 quarters · filed 2026-02-27 | $5.25M derived: sum of 3 quarters · filed 2026-02-27 | $6.73M 10-K · filed 2026-02-27 | ||||
| 2023-09-30 | $1.57M 10-Q · filed 2024-11-05 | $3.54M derived: sum of 2 quarters · filed 2024-11-05 | $5.02M 10-Q · filed 2024-11-05 | $5.77M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-06-30 | $1.97M 10-Q · filed 2024-08-06 | $3.45M 10-Q · filed 2024-08-06 | $4.20M derived: sum of 3 quarters · filed 2025-02-27 | $4.62M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-03-31 | $1.48M 10-Q · filed 2024-05-07 | $2.23M derived: sum of 2 quarters · filed 2025-02-27 | $2.65M derived: sum of 3 quarters · filed 2025-02-27 | $2.78M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2022-12-31 | $753.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $1.17M derived: sum of 2 quarters · filed 2025-02-27 | $1.30M derived: sum of 3 quarters · filed 2025-02-27 | $1.31M 10-K · filed 2025-02-27 | $910.00K 10-K · filed 2023-03-08 | |||
| 2022-09-30 | $420.00K 10-Q · filed 2023-11-09 | $375.00K 10-Q · filed 2022-11-09 | $551.00K derived: sum of 2 quarters · filed 2023-11-09 | $560.00K 10-Q · filed 2023-11-09 | $514.00K 10-Q · filed 2022-11-09 | $565.00K derived: sum of 4 quarters · filed 2024-02-27 | ||
| 2022-06-30 | $131.00K 10-Q · filed 2023-08-09 | $128.00K 10-Q · filed 2022-08-10 | $140.00K 10-Q · filed 2023-08-09 | $139.00K 10-Q · filed 2022-08-10 | $145.00K derived: sum of 3 quarters · filed 2024-02-27 | $150.00K derived: sum of 4 quarters · filed 2024-02-27 | ||
| 2022-03-31 | $9.00K 10-Q · filed 2023-05-09 | $11.00K 10-Q · filed 2022-05-06 | $14.00K derived: sum of 2 quarters · filed 2024-02-27 | $19.00K derived: sum of 3 quarters · filed 2024-02-27 | $25.00K derived: sum of 4 quarters · filed 2024-02-27 | |||
| 2021-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $10.00K derived: sum of 2 quarters · filed 2024-02-27 | $16.00K derived: sum of 3 quarters · filed 2024-02-27 | $17.00K 10-K · filed 2024-02-27 | $18.00K 10-K · filed 2022-03-04 | |||
| 2021-09-30 | $5.00K 10-Q · filed 2022-11-09 | $11.00K derived: sum of 2 quarters · filed 2022-11-09 | $12.00K 10-Q · filed 2022-11-09 | $12.00K derived: sum of 4 quarters · filed 2023-03-08 | ||||
| 2021-06-30 | $6.00K 10-Q · filed 2022-08-10 | $7.00K 10-Q · filed 2022-08-10 | $7.00K derived: sum of 3 quarters · filed 2023-03-08 | -$1.78M derived: sum of 4 quarters · filed 2023-03-08 | ||||
| 2021-03-31 | -$1.00K 10-Q · filed 2022-05-06 | $1.00K 10-Q · filed 2021-05-25 | $1.00K derived: sum of 2 quarters · filed 2023-03-08 | -$1.78M derived: sum of 3 quarters · filed 2023-03-08 | -$1.78M derived: sum of 4 quarters · filed 2023-03-08 | |||
| 2020-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | -$1.78M derived: sum of 2 quarters · filed 2023-03-08 | -$1.78M derived: sum of 3 quarters · filed 2023-03-08 | -$1.75M 10-K · filed 2023-03-08 | ||||
| 2020-09-30 | -$1.78M 10-Q · filed 2021-11-04 | -$1.78M derived: sum of 2 quarters · filed 2021-11-04 | -$1.75M 10-Q · filed 2021-11-04 | |||||
| 2020-06-30 | $3.00K 10-Q · filed 2021-08-05 | $36.00K 10-Q · filed 2021-08-05 | ||||||
| 2020-03-31 | $33.00K 10-Q · filed 2021-05-25 | |||||||
| 2019-12-31 | $111.00K 10-K · filed 2022-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |